FBTAX
Price
$24.91
Change
-$0.61 (-2.39%)
Updated
Apr 3 closing price
Net Assets
1.39B
LHCFX
Price
$17.98
Change
-$0.44 (-2.39%)
Updated
Apr 3 closing price
Net Assets
7.48M
Ad is loading...

FBTAX vs LHCFX

Header iconFBTAX vs LHCFX Comparison
Open Charts FBTAX vs LHCFXBanner chart's image
Fidelity Advisor Biotechnology A
Price$24.91
Change-$0.61 (-2.39%)
VolumeN/A
Net Assets1.39B
Lord Abbett Health Care F
Price$17.98
Change-$0.44 (-2.39%)
VolumeN/A
Net Assets7.48M
FBTAX vs LHCFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTAX vs. LHCFX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Hold and LHCFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.39B vs. LHCFX (7.48M). FBTAX pays higher dividends than LHCFX: FBTAX (2.97) vs LHCFX (0.48). FBTAX was incepted earlier than LHCFX: FBTAX (24 years) vs LHCFX (6 years). LHCFX (3.38) is less costly to investors than FBTAX (0.96). LHCFX is a more actively managed with annual turnover of: 88.00 vs. FBTAX (73.00). FBTAX (0) and LHCFX (0) have matching initial minimum investment requirements. LHCFX annual gain was more profitable for investors over the last year : -3.45 vs. FBTAX (-12.66). LHCFX return over 5 years is better than : 32.42 vs. FBTAX (10.53).
FBTAXLHCFXFBTAX / LHCFX
Total Expense Ratio0.960.78123%
Annual Report Gross Expense Ratio0.963.3828%
Fund Existence24 years6 years-
Gain YTD-6.211-5.052123%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B7.48M18,594%
Annual Yield % from dividends2.970.48622%
Returns for 1 year-12.66-3.45367%
Returns for 3 years2.83-1.02-277%
Returns for 5 years10.5332.4232%
Returns for 10 years-4.32N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FUNCX26.68N/A
N/A
Pioneer Fundamental Growth C
VNSYX20.97N/A
N/A
Natixis Vaughan Nelson Select Y
JSPJX18.69N/A
N/A
Jackson Square Large-Cap Growth Inv
FHOFX23.27N/A
N/A
Fidelity Series Large Cp Grwth Idx
MEGMX13.37N/A
N/A
Matthews Emerging Markets Equity Inv